Difficulty: Medium
Average Score: 94%
Practice
Who is least likely to be treated with somatropin?
Correct answer
A
Rationale
The correct answer is A) A 3-year-old cow on a dairy farm is least likely to be treated with somatropin. Somatropin is a synthetic form of human growth hormone used to treat growth hormone deficiency in humans. Cows do not have the same growth hormone deficiencies or genetic conditions that would necessitate the use of somatropin as in human patients.
Option B) A 4-year-old girl with an XO genetic genotype has Turner syndrome, a condition that often results in short stature and may benefit from somatropin treatment to support growth.
Option C) A 4-year-old boy with chronic renal failure and growth deficiency may require somatropin to help address growth issues associated with his condition.
Option D) A 10-year-old boy with polydipsia and polyuria may have diabetes insipidus or another endocrine disorder that could potentially benefit from somatropin treatment to address growth issues.
Educationally, understanding the appropriate use of somatropin based on underlying conditions and growth hormone deficiencies is crucial for healthcare providers to make informed treatment decisions for their patients. It is essential to consider the individual's medical history, genetic conditions, and endocrine disorders when determining the suitability of somatropin therapy.
Option B) A 4-year-old girl with an XO genetic genotype has Turner syndrome, a condition that often results in short stature and may benefit from somatropin treatment to support growth.
Option C) A 4-year-old boy with chronic renal failure and growth deficiency may require somatropin to help address growth issues associated with his condition.
Option D) A 10-year-old boy with polydipsia and polyuria may have diabetes insipidus or another endocrine disorder that could potentially benefit from somatropin treatment to address growth issues.
Educationally, understanding the appropriate use of somatropin based on underlying conditions and growth hormone deficiencies is crucial for healthcare providers to make informed treatment decisions for their patients. It is essential to consider the individual's medical history, genetic conditions, and endocrine disorders when determining the suitability of somatropin therapy.